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Alzheimer’s disease (AD) is a neurodegenerative pathology commonly characterized by a progressive and ir-
reversible deterioration of cognitive functions, especially memory. Although the etiology of AD remains un-
known, a consensus has emerged on the amyloid hypothesis, which posits that increased production of
soluble amyloid b (Ab) peptide induces neuronal network dysfunctions and cognitive deficits. However, the
relative failures of Ab-centric therapeutics suggest that the amyloid hypothesis is incomplete and/or that the
treatments were given too late in the course of AD, when neuronal damages were already too extensive. Hence,
it is striking to see that very few studies have extensively characterized, from anatomy to behavior, the alterations
associated with pre-amyloid stages in mouse models of AD amyloid pathology. To fulfill this gap, we examined
memory capacities as well as hippocampal network anatomy and dynamics in young adult pre-plaque TgCRND8
mice when hippocampal Ab levels are still low. We showed that TgCRND8 mice present alterations in hippocampal
inhibitory networks and g oscillations at this stage. Further, these mice exhibited deficits only in a subset of
hippocampal-dependent memory tasks, which are all affected at later stages. Last, using a pharmacological
approach, we showed that some of these early memory deficits were Ab-independent. Our results could partly
explain the limited efficacy of Ab-directed treatments and favor multitherapy approaches for early symptomatic
treatment for AD./adv
 on June 26, 2019
ances.sciencem
ag.org/INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative pathology com-
monly characterized by a progressive and irreversible deterioration
of cognitive functions, especially memory, which accentuates with
the progression of the disease. Although the etiology of AD remains
unknown, a consensus has emerged on the amyloid hypothesis (1),
which posits that the amyloid b (Ab) peptide, amajor constituent of the
amyloid plaques, induces neuronal network dysfunctions and is there-
fore responsible for the alteration of cognitive functions (2). Ab derives
from the amyloidogenic cleavage of the transmembrane amyloid pre-
cursor protein (APP, also called b-amyloid precursor protein), first
by the b-secretase enzyme (b-secretase or BACE-1), which generates
soluble APP (sAPP) and the b–C-terminal fragment (b-CTF, also called
C99). b-CTF is then cleaved by the g-secretase enzyme (g-secretase) to
generate the Ab peptide and the amyloid intracellular domain (AICD).
Ab, principallyAb containing 42 amino acids (Ab42), aggregates to form
Ab oligomers and extracellular amyloid plaques. Over the last 15 years
or so, it has become clear that neural networks and memory impair-
ments are due to increased brain levels of soluble forms of Ab (3, 4)
rather than amyloid fibrils or amyloid plaques (5). Thus, efforts aimed
at loweringAb levels have been deployed as a possible treatment forAD,
mainly by using g-secretase inhibitors. However, these drugs paradox-
ically induced no improvement or even worsened cognitive function
and/or had drastic side effects that preclude their use as suitable thera-
peutics for AD (6). The lack of obvious beneficial effects on cognition
suggests that Ab alone is unable to account for all aspects of the disease
(7, 8). Accordingly, other amyloid factors, such as b-CTF (9–15), AICD(16), or the newly described CTF-h (17), could represent possible cul-
prits in early AD. Therefore, characterizing whether different APP
cleavage products contribute differentially to early cognitive deficits (that
is, before amyloid plaque apparition) is of utmost importance. To this
aim, we performed a comprehensive characterization of 2-month-old
male TgCNRD8 mice and their nontransgenic control littermates
(NTg). At this age, TgCRND8 mice exhibit no plaques and low levels
of Ab associated with high expression of b-CTF within the hippocam-
pus. We first showed that these mice present drastic alterations in CA1
inhibitory networks and g oscillations, indicating that hippocampal net-
works are affected early in the time course of the amyloid pathology.
Even ifmultiple forms ofmemory are affected inAD, specific functions
such as recognition memory for objects, detection of spatial changes,
and spatial navigation seem precociously altered (18–20). Although
these forms of memory rely on complex interstructure dialogs encom-
passing the temporal lobe and prefrontal cortex, most of them are
known to be dependent on the integrity of hippocampal networks
[for a recent review on recognition memory, see the study of Ameen-
Ali et al. (21)]. Therefore, the early hippocampal alterations reported in
youngTgCRND8micemight be responsible for some subtlememory
impairment. Accordingly, pre-plaque TgCRND8 mice exhibited a par-
ticular pattern of memory deficits: They were impaired in both spa-
tial object location and object-place association tasks, but they
performed as well as their NTg littermates in the novel object recogni-
tion task and the Barnes maze spatial navigation task. Last, because
both b-CTF and Ab were detected in the hippocampus of pre-plaque
TgCRND8 mice, it was critical to assess the respective role of each
APP fragment in the reported memory deficits. To target different
APP cleavage products, we chronically treated TgCRND8 mice and
their NTg littermates with either b- or g-secretase inhibitors. We
showed that behavioral deficits in the spatial object location task were
most likely Ab-dependent because they were rescued by both the1 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L Eb- and g-secretase inhibitors, which precludes Ab generation, while def-
icits in the object-place association task were likely Ab-independent be-
cause they were rescued only by the b-secretase inhibitor, which
prevents both Ab and b-CTF production. Further, we showed that
Ab and b-CTF likely act on specific hippocampal networks. Overall,
our study indicates differential contributions of APP amyloid metab-
olites to early memory deficits, highlighting the complexity of devel-
oping an effective therapeutic strategy against AD. on June 26, 2019
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RESULTS
Hippocampal amyloidogenic state in young TgCRND8 mice
To characterize the hippocampal amyloid state in young pre-plaque
TgCRND8 mice [before 3 months of age (22)], we performedWestern
blot analysis of a whole hippocampal extract using the APP C-term
antibody (which recognizesmurine as well as humanmutated APP and
related proteolytic products) in 1- and 2-month-old TgCRND8 and
NTg littermate mice. As already described in the study of Goutagny
et al. (9) and in the study of Cavanagh et al. (23), youngTgCRND8mice
exhibited an age-dependent increase of CTF levels in the hippocampus
[two-way analysis of variance (ANOVA): interaction age × genotype:
F1,22 = 4.342, P = 0.049; Bonferroni post hoc between 1- and 2-month-
old TgCRND8: t22 = 4.262, P = 0.0019; Fig. 1A]. The anti-human Ab
antibody (6E10) applied on the same samples did not detect Ab at
these ages but revealed and confirmed the increased level of human
b-CTF (fig. S1). To test whether Ab was present in hippocampal net-
works, we performed enzyme-linked immunosorbent assay (ELISA)
analyses on a subset of these extracts; this approach allowed the de-
tection of very small quantities of Ab (around 0.2 ng/mg of hippo-
campal protein homogenates). Although Ab was not detectable in
NTg animals, low levels were present in TgCRND8 mice starting at
1 month of age, with a tendency to increase at between 1 and 2 months
(t8 = 1.505, P = 0.1707; Fig. 1B). Therefore, in addition to b-CTF, the
hippocampus of young TgCRND8 mice also contains Ab.
Hippocampal network structure and function in young
TgCRND8 mice
To determine whether the amyloidogenic state described above could
be linked to alterations in hippocampal activity as already described
in vitro (9), we performed in vivo multisite electrophysiological record-
ings in urethane-anesthetized animals. We used 16-channel linear
silicon probes to simultaneously record from different layers of theHamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017dorsal hippocampus (CA1, from stratum oriens to stratum lacunosum
moleculare; Fig. 2A). Both TgCRND8 (n = 8) and NTg mice (n = 11)
exhibited clear q oscillations after sensory stimulation in all CA1 layers
(Fig. 2A). We then quantified the integrated power of total, q, slow
g (SG), and fast g (FG) oscillations in the CA1 area. No differences
were found between genotypes in both total and q powers (two-way
ANOVA for total power: genotype effect: F1,17 = 0.3680, P = 0.5521;
two-way ANOVA for q power: genotype effect: F1,17 = 0.2852, P =
0.6002; Fig. 2B). However, a slight decrease in q frequencywas observed
(controls versus TgCRND8: t17 = 2.195, P = 0.0423). g Oscillatory
activity was largely impaired in young TgCRND8 mice in both the
SG (two-way ANOVA for SG power: interaction depth × genotype:
F8,136 = 3.182, P = 0.0024; Fig. 2B) and FG ranges (two-way ANOVA
for FG power: interaction depth × genotype: F8,136 = 2.299, P =
0.0242; Fig. 2B).
At the cellular level, inhibitory interneurons expressing either parv-
albumin (PV) or somatostatin (SOM) have been critically linked to
hippocampal oscillatory activity (24, 25) and have been shown to
be precociously altered in mouse models of AD (26, 27). Therefore,
we performed immunolabeling of SOM and PV interneurons in the
hippocampus of young TgCRND8 and NTg littermates (Fig. 3A).
More specifically, we quantified the numbers of SOM and PV in-
terneurons in the different subfields of the dorsal hippocampus. Al-
though no difference was found in the number of SOM interneurons
(two-way ANOVA: genotype effect: F1,7 = 0.2589, P = 0.6265; Fig.
3A), we could show that TgCRND8 mice exhibited a significant de-
crease of PV interneurons specifically in the CA1 area (two-way
ANOVA: genotype effect: F1,7 = 7.461, P = 0.0293; hippocampal sub-
field effect: F3,21 = 212.5, P < 0.0001; Bonferroni post hoc test for CA1:
t28 = 3.680, P = 0.0039; Fig. 3A). To confirm that the decrease in the
number of immunofluorescent PV interneurons found in TgCRND8
mice resulted from a decrease in the number of cells rather than a
decrease in PV expression per se, we quantified the level of voltage-
gated sodium channel subunits NaV1.1 and NaV1.6, which are pre-
dominant in PV cells (26). These experiments demonstrated that
TgCRND8 mice exhibited a significant decrease in the expression of
NaV1.6 (NTg versus TgCRND8: t9 = 3.1, P = 0.0127) and also sug-
gested a decrease for the NaV1.1 subunit (NTg versus TgCRND8:
t9 = 2.015, P = 0.0747; Fig. 3B). Together, these results indicate that
young TgCRND8 mice present profound alterations in dorsal hip-
pocampal CA1 PV inhibitory networks, likely leading to altered g
oscillations.Fig. 1. Semiquantitative analyses of the expression of APP and APP metabolites in 1- and 2-month-old TgCRND8 and control littermate mice. (A) Western blot
using the APP C-term antibody and quantification of APP and CTF levels. Note the specific increase in CTF levels in 2-month-old TgCRND8 mice compared to 1-month-
old animals. (B) Hippocampal Ab42 dosage in 1- and 2-month-old NTg and TgCRND8 mice. Ab42 is below detection level in NTg animals. Despite a tendency to an age-
dependent increase, Ab levels remain low in both groups. *, difference between groups (**P < 0.01 and ***P < 0.0001); ND, non detectable.2 of 11
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Behavioral performances of young TgCRND8 mice
Hippocampal oscillatory activity has been described as a critical player
inmemory encoding, consolidation, and retrieval. To determinewheth-
er the specific alterations found in dorsal hippocampal CA1 networks
could be linked to cognitive deficits, we performed a battery of behav-
ioral tests in young adult 2-month-old male TgCRND8 mice. We first
used three tests relying on spatial information treatment by dorsal CA1
hippocampal networks: the spatial object location task (28, 29), the
object-place association task (28, 30), and the Barnes maze task (31).
TgCRND8 mice were impaired in both the spatial object loca-
tion task (different from chance level: NTg: t13 = 2.311, P = 0.0379;
TgCRND8: t9 = 0.8115, P = 0.483; group difference: NTg versus
TgCRND8: t22 = 1.735, P = 0.0968; Fig. 4A and fig. S2) and the object-
place association task (different from chance level: NTg: t13 = 2.311,
P = 0.0379; TgCRND8: t9 = 0.8115, P = 0.483; group difference: NTg
versus TgCRND8: t22 = 2.046, P = 0.05; Fig. 4B and fig. S3). However,
they performed aswell as the control littermates in the Barnesmaze task
either in the learning phase or during the probe test (two-way ANOVA
for learning: genotype effect: F1,21 = 1.896, P = 0.183; two-way
ANOVA for probe: genotype effect: F1,21 = 1.595, P = 0.2205; Fig. 4C
and fig. S4).Hamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017Mice were also tested in a short-term novel object recognition task,
which is mainly considered as hippocampal-independent [see the
study of Ameen-Ali et al. (21) for a recent review]. TgCRND8 mice
performed as well as their respective control littermates, with a clear
detection of the novel object (different from chance level: NTg: t13 =
4.255, P = 0.0009; TgCRND8: t12 = 3.151, P = 0.0084; group difference:
NTg versus TgCRND8: t25 = 0.8203, P = 0.4198; Fig. 4D and fig. S5).
Together, these results indicate that pre-plaque TgCRND8 mice ex-
hibited early cognitive deficits only in a subset of hippocampal-
dependent tasks.
Differential involvement of b-CTF and Ab in early
cognitive deficits
Because both b-CTF and Ab were detected in the hippocampus of
young TgCRND8 mice, it was critical to assess their respective role,
if any, in the cognitive deficits reported above. To do so, we chronically
treated NTg and TgCRND8 mice with either a b-secretase inhibitor
[LY2811376, 15mg/kg every 2days for 1monthbetween1 and2months;
this drug decreases both b-CTF and Ab levels without affecting the ex-
pression of APP (32)] or a g-secretase inhibitor [semagacestat, 10mg/kg
per day for 8 days; this drug decreases Ab levels but increases b-CTFFig. 2. Alterations in hippocampal oscillatory activity in pre-plaque TgCRND8 mice. (A) Both TgCRND8 and NTg mice exhibit clear q oscillations after sensory
stimulation in all CA1 subfields. (B) No differences were found between genotypes in both total and q power. g Oscillatory activity was largely impaired in pre-plaque
TgCRND8 mice in both the SG and FG range. (*, difference between groups; *P < 0.05 and **P < 0.01).Fig. 3. Alterations in hippocampal PV inhibitory network in pre-plaque TgCRND8 mice. (A) Photomicrograph of the dorsal hippocampus from NTg and pre-
plaque TgCRND8 mice [PV, red; SOM, green; 4′,6-diamidino-2-phenylindole (DAPI), blue]. Scale bars, 200 mm. No change was seen in the number of SOM interneurons
whatever the hippocampal subfield. However, pre-plaque TgCRND8 mice exhibited a significant decrease in PV interneurons only in the CA1 area of the dorsal hip-
pocampus. (B) Western blot analyses of hippocampal expression of NaV1.1 and NaV1.6 subunits. TgCRND8 mice exhibited a significant decrease in the expression of
NaV1.6 and a clear tendency toward a decrease for the NaV1.1 subunit. *, difference between genotypes, Bonferroni post-hoc test, *P < 0.05 and **P < 0.01.3 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L Econtents (12)]. Mice were tested at the age of 2months in the spatial ob-
ject location task followed by the object-place association task.None of
the treatments had an effect onmemory performance in NTg animals
(one-way ANOVA for the spatial object location task: F2,41 = 0.3607,
P = 0.6993; one-way ANOVA for the object-place association task:Hamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017F2,42 = 0.2040, P= 0.8163; Fig. 5, A and B, and fig. S6). Both treatments
were able to rescue retention performances of TgCRND8 mice in the
spatial object location task (different from chance level: NTg-vehicle:
t23 = 6.61, P < 0.0001; NTg-LY2811376: t6 = 6.951, P = 0.0004; NTg-
semagacestat: t12 = 4.444, P = 0.0008; TgCRND8-vehicle: t21 = 0.6681, on J
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Fig. 4. Behavioral characterization of 2-month-old pre-plaque TgCRND8 mice. Pre-plaque TgCRND8 mice presented drastic alterations in the spatial object location
task (A) and the object-place association task (B). However, they performed as controls in the Barnes maze task during the training phase and the probe test (C) as well
as the novel object recognition task (D). *, difference between genotypes; #, different from chance.une 26, 2019Fig. 5. Differential effect of b-secretase (LY2811376) and g-secretase (semagacestat) inhibition on memory performances in pre-plaque TgCRND8 mice. (A) Both b-
and g-secretase inhibitors rescued retention performances in the spatial object location task. (B) However, in the object-place association task, only the b-secretase inhibitor
was effective. (C) LY2811376 and semagacestat differentially affected APP metabolite production. Although both treatments decreased Ab levels, LY2811376 and
semagacestat have opposite effects on b-CTF levels. (*, difference between genotypes * P < 0.05, ** P < 0.01, and *** P < 0.001); #, difference from chance; &, difference
from TgCRND8 + vehicle (&&P < 0.01, &&&p < 0.001, and &&&&P < 0.0001).4 of 11
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P = 0.5113; TgCRND8-LY2811376: t9 = 3.106, P = 0.0126; TgCRND8-
semagacestat: t11 = 2.303, P = 0.0418; Fig. 5A) without affecting the
total exploration time during the acquisition trial (fig. S7). Two-way
ANOVA revealed only a genotype effect (F1,8 = 7.156, P= 0.009), and
the Bonferroni post hoc analysis showed that TgCRND8mice exhibited
a decrease in retention performances compared to NTg littermates
only in the vehicle-treated group (t82 = 3.3, P = 0.0043). Surprisingly,
only the LY2811376 treatment was able to rescue memory perform-
ances in the object-place association task, with no effect of the semaga-
cestat treatment (different fromchance level:NTg-vehicle: t24 = 3.259,P=
0.0033; NTg-LY2811376: t6 = 7.405, P = 0.0003; NTg-semagacestat: t11 =
2.264, P = 0.0448; TgCRND8-vehicle: t19 = 3.523, P = 0.0023;
TgCRND8-LY2811376: t9 = 2.230, P = 0.05; TgCRND8-semagacestat:
t10 = 0.9314, P = 0.3736; Fig. 5B). Neither the LY2811376 treatment
nor the semagacestat treatment affected total object exploration during
the acquisition trial (fig. S8). Two-way ANOVA revealed a genotype
effect (F1,80 = 13.98, P = 0.0003) and a treatment effect (F2,80 = 3.594,
P = 0.032) without interaction (F2,80 = 1,299, P = 0.2786). Bonferroni
post hoc analysis revealed that TgCRND8 mice exhibited a decrease
in retention performances as compared to NTg littermates in both
the vehicle-treated group (t80 = 4.176,P=0.0002) and the semagacestat-
treated group (t80 = 2.429, P = 0.05) but not in the LY2811376-treated
group (t80 = 0.7348, P > 0.999). To confirm the effect of both treatments
on hippocampal APPmetabolite expression, we quantified the levels
of Ab using ELISA and those of b-CTF using Western blot analysis
(Fig. 5C). As already shown in the study of Mitani et al. (12) and the
study of May et al. (32), we found that hippocampal Ab concentration
was reduced following both treatments (one-sample t test against
TgCRND8-vehicle: TgCRND8-LY2811376: t4 = 2.536, P = 0.0642;
TgCRND8-semagacestat: t8 = 4.346, P = 0.0026). In addition, we also
confirmed that hippocampal b-CTF contents were decreased following
the LY2811376 treatment but increased after the semagacestat treatment
(one-sample t test against TgCRND8-vehicle: TgCRND8-LY2811376:
t4 = 14.42, P = 0.0001; TgCRND8-semagacestat: t8 = 14.30, P <
0.0001). Given the distinct effect of LY2811376 and semagacestat treat-
ments on both APP metabolite levels and cognitive performances, it is
likely that different APP metabolites are responsible for the deficits of
TgCRND8 mice in the spatial object location task and in the object-
place association task.Hamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017Differential effect of b- and g-secretase on dorsal
hippocampal network functioning
Because TgCRND8 mice exhibit specific alterations in CA1 PV net-
works, we wondered whether LY2811376 and/or semagacestat treat-
ments might act via a rescue of CA1 interneuronal networks. To this
aim, we performed immunolabeling of PV interneurons in a subset
of NTg and TgCRND8 mice following vehicle or pharmacological
treatment (vehicle: n = 7 NTg and 8 TgCRND8; LY2811376: n = 3
TgCRND8; semagacestat: n = 6 TgCRND8). None of the treatments
were able to rescue the PV interneuron network in TgCRND8 mice
(one-way ANOVA: F3,20 = 6.56, P = 0.0029; Fig. 6). The number of
PV+ neurons was still significantly decreased following semagacestat
(Bonferroni post hoc test: t20 = 3.807, P= 0.0066) or LY2811376 treat-
ment (Bonferroni post hoc test: t20 = 3.467, P = 0.00146; Fig. 6). In
addition to a decrease in PV+ cells, young TgCRND8 mice exhibit a
decrease in NaV expression. Because restoring NaV levels in amouse
model ofADrestoresmemory deficits (26), we testedwhether LY2811376
and/or semagacestat might rescue NaV1.1 and/or NaV1.6 levels in
the hippocampus. We showed that semagacestat was able to rescue
levels of bothNaV1.1 andNaV1.6, while LY2811376 only rescued those
of NaV1.6 (one-way ANOVA for NaV1.1: F3,23 = 6.52, P = 0.0024;
one-way ANOVA for NaV1.6: F3,23 = 5.911, P = 0.0038; Fig. 6).
Therefore, beneficial effects of b- and g-secretase inhibitor treatments
on the spatial object location task might be mediated, in part, by a
rescue of the NaV levels, thereby restoring “normal” PV interneuron
function (26).
We then questioned how LY2811376 might rescue memory per-
formances in the object-place association task. Semagacestat appears
more powerful than LY2811376 in rescuing PV interneuron function
in CA1, but it has no effect on the object-place deficit. Thus, another
region could have mediated the beneficial effect of LY2811376 in the
object-place task. Because some studies indicate that upstream regions
of CA1might be involved (33), we performed c-Fos immunolabeling
of activated cells in the dorsal hippocampus following the object-
place association task in NTg and TgCRND8 mice. We found that
the dentate gyrus was the most activated hippocampal area during
the task (two-way ANOVA: hippocampal subregion effect: F2,24 =
51.53, P < 0.001; Fig. 7A). Strikingly, dentate activation during the task
was markedly reduced in TgCRND8 mice (interaction genotype ×19Fig. 6. Differential effect of b-secretase (LY2811376) and g-secretase (semagacestat) inhibition on PV network. b- and g-secretase inhibitors did not rescue PV
number in the CA1 area of the dorsal hippocampus. However, they both rescued NaV levels albeit using different mechanisms. Whereas semagacestat rescue both
NaV1.1 and NaV1.6 levels, LY2811376 only rescued NaV1.6 levels. *, difference between groups (* P < 0.05, ** P < 0.01).5 of 11
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hippocampal subregion: F2,24 = 31.22, P < 0.0001; Bonferroni post
hoc test: t36 = 8.071, P < 0.0001; Fig. 7A). Therefore, we hypothesized
that LY2811376 might rescue normal activation of dentate networks
during the object-place association task. Thus, we counted c-Fos–
immunolabeled cells in the dentate gyrus of TgCRND8 mice following
LY2811376 and semagacestat treatment. We found that treatment
with LY2811376, but not semagacestat, increases the number of acti-
vated cells in the dentate network during the task, albeit not to the
level of NTg animals (one-way ANOVA: F3,17 = 36.53, P < 0.001; Fig. 7B).
Therefore, LY2811376might rescuememory deficits in the object-place
association task via an effect on dentate networks. on June 26, 2019
g.org/DISCUSSION
This study demonstrates that pre-plaque TgCRND8 mice exhibit
early behavioral alterations only in a subset of hippocampal-
dependent tasks associated with drastic deficits in hippocampal in-
hibitory networks and altered g oscillations. Strikingly, we showed
that different APP metabolites were likely responsible for specific
memory deficits in two different tasks. Overall, our study supports
the current hypothesis that Ab is unable to account for all aspects
of cognitive impairments in AD, highlighting the complexity of the
amyloid pathology.
As the field inches toward early detection of AD to provide preco-
cious treatment (34), it is critical to assess the respective role of each
APP fragment in the earliest stage of the disease. Hence, we focused
our work on young adult TgCRND8 mice, a well-characterized mouse
model of AD-like amyloid pathology (22). In this mouse model, robust
expression of Ab begins around 10 weeks of age, and amyloid deposits
appear at 3 months (22). Therefore, we characterized the expression
of APP and its proteolytic products in TgCRND8 mice before the
“transition point” of high Ab production (10 weeks of age). By
combining Western blot and ELISA dosage approaches, we showed
that 1- and 2-month-old TgCRND8 mice expressed low Ab levels
together with high expression of b-CTF in the hippocampus. To deter-
mine whether the amyloidogenic state described above (low Ab and
high b-CTF levels) could be linked to alterations in hippocampal
functioning as already described in vitro (9), we performed in vivoHamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017multisite electrophysiological recordings in urethane-anesthetized
animals. We found that 2-month-old TgCRND8 mice presented
drastic alterations in g oscillations in the CA1 area. At the cellular
level, hippocampal GABAergic neurons are susceptible to Ab toxicity
in vitro and are affected in TgCRND8 mice (35). Two interneuron
subtypes are considered to be critical in themodulation of hippocampal
oscillatory activity: interneurons expressing PV (24, 36) and those
expressing SOM (36, 37). We showed that TgCRND8 mice exhibit
amarkeddecrease in thenumber of PV+ interneurons, specificallywith-
in the CA1 area of the dorsal hippocampus. In addition, the concom-
itant decreases in the expression of the voltage-gated sodium channel
subunits (NaV1.1 andNaV1.6) likely indicate a loss of PV interneurons
per se rather than a decrease in PV expression. However, SOM inter-
neurons are preserved in all subfields of the dorsal hippocampus in
TgCRND8 mice. These results seem to contradict those reported by
Albuquerque et al. (38), who showed no decrease in the number of
PV interneurons but a reduction in the SOM interneurons in 6-month-
old TgCRND8 mice. However, in this study, the authors counted
PV and SOM cells in the whole hippocampus, including its ventral
part, while we focus our investigation on different subfields of the dor-
sal hippocampal network. Therefore, it is highly possible that inter-
neuron networks might be differentially affected by the amyloid
pathology in the dorsal and ventral hippocampus. Nevertheless, our
study clearly indicates that pre-plaque young TgCRND8mice present
drastic and specific deficits in dorsal CA1 inhibitory networks asso-
ciated with altered g oscillations.
To determine whether these early hippocampal alterations could
be linked to cognitive deficits, we performed a large battery of behav-
ioral tasks taxing different types of memories for objects and/or their
spatial relationship (novel object recognition, spatial object location,
and object-place association tasks), as well as spatial navigationmemory
(Barnes maze task). These types of memory are known to depend crit-
ically on intact hippocampal function, with the notable exception of
short-term object recognition memory, which appears to rely more
on perirhinal cortex integrity (21).We were able to show that 2-month-
old TgCRND8 mice present a specific pattern of memory deficits
because they were impaired in the spatial object location and the object-
place association tasks, while their capacity to discriminate novelty inFig. 7. Differential effect of b-secretase (LY2811376) and g-secretase (semagacestat) inhibition on dorsal hippocampal activation during the object-place
association task. (A) Photomicrograph of the dorsal hippocampus from NTg and pre-plaque TgCRND8 mice (c-Fos, green; DAPI, blue). Scale bars, 200 mm. Note the
high number in c-Fos–labeled neurons in the dentate gyrus of NTg animals following the object-place association task. This dentate activation is absent in pre-plaque
TgCRND8 mice. (B) LY2811376, but not semagacestat treatment, increased the number of activated cells in the dentate network during the task, albeit not to the level
of NTg animals. *, difference between groups (**P < 0.01, ***P < 0.001).6 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 on June 26, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
the novel object recognition task and their spatial navigation abilities in
the Barnes maze task were preserved. The pattern of deficits de-
scribed in the present study is in partial agreement with those already
published in earlier studies on TgCRND8 mice. Although we also
found no impairment in spatial navigation memory before increased
production of Ab (39, 40), Francis et al. (39) reported alterations in
the novel object recognition task in 2-month-old TgCRND8 mice.
However, this study used both males and females, whereas we only
usedmalemice to avoid the well-known, gender-related variations in
amyloid physiopathology (41–43). In addition, and given the ac-
celerated amyloid pathology in this mouse model, we were extremely
careful to control the age of the animals at testing, with less than 1-day
variation between all groups (see Materials and Methods). Together,
our results indicate that pre-plaque TgCRND8 mice exhibit early def-
icits only in a limited set of memory tasks, which depends on the dor-
sal hippocampal region. Further, our results show that specific CA1
subcircuits might be specifically implicated in different processes. As
an example, a selective removal of PV interneurons from the CA1 area
of the hippocampus induced selective alterations in spatial working
memory but not spatial reference memory tasks (44).
We also show that both semagacestat and LY2811376 treatments
inhibiting Ab production rescued spatial object location memory,
but only the LY2811376 treatment inhibiting b-secretase activity was
able to rescue object-place association memory. This result suggests
a differential involvement of APPmetabolites in memory deficits of
2-month-old TgCRND8 mice. First, the effectiveness of b- and g-
secretase inhibition in reducing both hippocampal Ab and deficits
in the spatial object location task, despite an increased hippocampal
b-CTF level after g-secretase inhibition, suggests that object location
memory deficits of 2-month-old TgCRND8 mice are essentially Ab-
dependent. Although these treatments further reduce an already very
low level of hippocampal Ab, it has been shown that very low amounts
of intracellular Ab are sufficient to affect basal synaptic transmission
in the CA1 area (45). As previously reported, specific alterations in PV
networks (46, 47) impair object location memories. Thus, a specific
dysfunction of the dorsal CA1 reflected by the reported specific loss
of PV interneurons and concomitant alterations in g oscillatory ac-
tivities could explain on its own the deficit in the spatial object location
task in 2-month-old TgCRND8male mice. Therefore, we expected that
b- and g-secretase inhibition might rescue PV interneuronal deficits
of youngTgCRND8mice.Our results showed that the beneficial effect
of both treatments on the spatial object location task might be
mediated, in part, by a rescue of the NaV levels, thereby likely restoring
normal PV function (26). On the other hand, deficits in the object-place
association task were more likely related to high levels in hippocampal
b-CTFof 2-month-oldTgCRND8mice. b-Secretase inhibitionmarkedly
reduced b-CTF and rescued this deficit, whereas the ineffective g-secretase
inhibitor treatment further increasedhippocampalb-CTF levels. Alterna-
tively, b-secretase inhibition also increases the a-secretase pathway,
leading to increased production of the secreted human APPa, a frag-
ment known to improve memory performance at very low doses on a
wide rangeof tasks and inmodels ofAD(48–50). Further, the b-secretase
cleavage leads to a second important fragment that consists of a large
secreted ectodomain (often named sAPPb). The physiological roles of
sAPPb are poorly known, but there is a general agreement that it has
neuroprotective, neurotrophic, and activity-regulating effects similar
to sAPPa, although to a lesser extent [see the study of Chasseigneaux
andAllinquant (51) for a review].Therefore, it ismore likely thatmemory
defects modulated specifically by the b-secretase cleavage are related toHamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017the alternative b-CTF fragment clearly identified as neurotoxic (9–11).
Some studies have shown that high levels of b-CTFmay have deleterious
effects on memory processing (12, 15, 52). It is unlikely that b-CTF–
inducedmemory deficits in the object-place association task were related
to the reported alterations in CA1 PV inhibitory network because sema-
gacestat treatment efficiently rescued the latter but not object-place
performances. This task is known to depend on the hippocampal
network’s integrity (53, 54); thus, other hippocampal subfields
might be implicated. To test this hypothesis, we performed c-Fos
labeling of activated cells during the object-place association task.
We found that the dentate gyrus was the most activated hippocampal
area during the task in NTg animals. Further, this dentate activation
was markedly reduced in TgCRND8 mice. Therefore, alterations in the
object-place association task in young TgCRND8 mice might be due,
in part, to alterations in dentate networks. We therefore hypothesized
that b-secretase inhibition might rescue normal activation of dentate
networks during the object-place association task. LY2811376, but not
semagacestat, treatment increased the number of activated cells in the
dentate network during the task, albeit not up to the level ofNTg.There-
fore, b-CTFmight preferentially impact dentate network’s function. Al-
ternatively, the object-place association task has also been shown to
depend on the integrity of the lateral entorhinal cortex (33, 55), one of
the main input to the dentate gyrus. Therefore, b-CTF might also pre-
cociously affect functioning of brain areas upstreamof the hippocampus.
In conclusion, our study clearly indicates that some earlymemory
deficits in a pre-plaque mouse model of AD are Ab-independent.
Most pharmaceutical companies seeking disease-modifying treatments
for AD have investigated Ab-centric therapeutics. However, several
of these drugs havemet end points in phase 2 and phase 3 trials, because
they paradoxically worsened or failed to substantially improve cognitive
functions (6, 56). The lack of beneficial effects on cognition suggests
that Ab alone is unable to account for all aspects of the disease (7, 8).
Therefore, our study complements the current amyloid hypothesis,
which posits that Ab triggers synaptic and memory dysfunctions in
AD (57). Our pharmacological results confirm a key role for soluble
Ab peptides in some of the memory deficits described here. In general,
our results indicate that selective b-secretase inhibitors remain an at-
tractive approach forAD treatment.However, because b‐secretase also
interacts with many substrates (58), our results would rather favor the
use of low-dose multitherapies targeting both b- and g-secretase for
early symptomatic treatment of AD.MATERIALS AND METHODS
Animals
One- and 2-month-old male TgCRND8mice and their age-matched
NTg littermates were used in this study (1 month old: n = 5 NTg and
n = 10 TgCRND8mice; mean age, 29.75 ± 0.2 and 30.63 ± 0.23 days,
respectively; 2 month old: n = 92 NTg and n = 85 TgCRND8 mice;
mean age, 60.44 ± 0.21 and 60.01 ± 0.18 days, respectively). TgCRND8
mice express a double-mutant (Swedish, KM670/671NL; Indiana,
V717F) form of the human APP gene under control of the Syrian
hamster PrP gene promoter (22). These mice were bred on a hybrid
C57BL/6-C3H background and maintained in a temperature- and
humidity-controlled room under a 12-hour light/dark cycle (lights
on at 7:00 a.m.) with ad libitum access to food andwater. Youngmice
were separated from the mother and housed in groups of two or three
at 4 weeks of age and then individually housed 1 week before the start
of the experiments, which were conducted during the light phase of7 of 11
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the cycle. Mice homozygote for the retinal degeneration Pdebrd1 (rd)
mutation were excluded from the study. In accordance with the Euro-
pean Union laws for animal studies, all procedures were approved by
the institutional ethics committee (authorization numbers AL/02/
08/04/12 and APAFIS#618-2015050510019910).
ELISA and Western blot
Mice were sacrificed by cervical dislocation, and their brains were
carefully dissected on ice. Hippocampi were quickly removed and
frozen in liquid nitrogen and stored at −80°C. For quantification of
APP, b-CTF, and Ab, hippocampi were homogenized in 10 volumes
of ice-cold radioimmunoprecipitation assay buffer containing protease
inhibitor cocktail (Sigma-Aldrich), phosphatase inhibitor cocktail
(PhosStop, Roche Life Science), and 1 mM phenylmethylsulfonyl
fluoride (Sigma-Aldrich). After centrifugation at 20,000g for 20 min
at 4°C, supernatants were aliquoted for immunoblot analysis and
ELISA. Protein concentration was measured using the Bio-Rad Protein
Assay (Bio-Rad).
For immunoblot analysis, samples (20 mg of protein per lane) were
separated by 4 to 20% precast gel (Mini-Protean and Criterion TGX
precast gels, Bio-Rad) electrophoresis and transferred to nitrocellulose
membranes using the Trans-Blot Turbo System (Bio-Rad). After
blocking in 5% skimmedmilk for 1 hour at room temperature, mem-
branes were incubated overnight at 4°Cwith primary antibodies diluted
in 2% bovine serum albumin (Sigma) in tris-bufferd saline 0.05%
Tween 20 (Sigma-Aldrich) followed by anti-mouse or anti-rabbit
immunoglobulins conjugated to horseradish peroxidase (Jackson
Immunoresearch) for development with enhanced ECL chemi-
luminescence detection kit (Thermo Fisher Scientific) and exposed
to CL-XPosure Film (Thermo Fisher Scientific). After detection, all
membranes were reprobed with anti-actin antibody for normalization
of total protein. The quantification of the band intensity was performed
by densitometry analysis using the ImageJ program.
The different antibodies used were mouse monoclonal anti–Ab
(6E10, 1:10,000; Covance), rabbit polyclonal anti-APP, C terminus
(1:4000; Sigma-Aldrich), mouse monoclonal anti-actin (1:10,000;
Sigma-Aldrich), rabbit polyclonal anti-NaV1.1 and rabbit polyconal
anti-NaV1.6 (1:500 and 1:1000, respectively; Alomone Labs), and
peroxidase-conjugated AffiniPure goat anti-mouse and goat anti-rabbit
(1:10,000; Jackson Immunoresearch). For sandwich ELISA, we used
the humanAb(1–42) high sensitivity ELISA kits (IBL International). All
ELISA assayswere performed according to themanufacturer’s protocol.
The signalwas normalized to the protein concentration for each sample.
All dosages were done using duplicates, and samples with variation
>10% between duplicates were discarded from analysis.
In vivo electrophysiology under urethane anesthesia
Mice under urethane (1.8 g/kg; Sigma-Aldrich) terminal anesthesia
were placed in a stereotaxic apparatus after the complete loss of tail
and paw-pinch retraction reflexes. Recording coordinates in the dor-
sal hippocampus were calculated from bregma (dorsal hippocampus:
anteroposterior, −2 mm; mediolateral, ±0.15 mm). Recordings were
done with a linear 16-channel silicon probe (NeuroNexus, A1x16-
2mm-50-177) connected to an AlphaLab recording system (Alpha
Omega). Raw signal was amplified (200×), filtered between 0 and
9 kHz, and digitalized at 22 kHz. Silicon probes were painted with
2%DiI solution (Sigma-Aldrich) for localization. Analyses were carried
out using custom-made scripts inMatlab (MathWorks).When present,
slow drift and electrical noise were removed using the Chronux signalHamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017processing toolbox (59). Local field potential data were downsampled
to 2200 Hz and filtered between 0.1 and 500 Hz. Spectral analysis was
carried with the Chronux toolbox with a time-frequency product of
three and five tapers. Time-frequency analyses were done on a 4-s
window moved across the data in 1-s increments. Urethane anesthesia
was characterized by alternating q and non-q states (60). Only periods
associated with q (q/d power ratio > 5) were analyzed. Spectral power
was calculated as the integrated power for q (3 to 9 Hz under urethane
anesthesia), SG (25 to 45 Hz), and FG (60 to 100 Hz).
Behavior
Novel object recognition, spatial object location, and
object-place association tasks.
The recognition memory tasks used in this study were based on the
spontaneous tendency of mice to preferentially explore a new object
(novel object recognition task), an object thatmoved to a new location
(spatial object location task), or a known object replacing a different
object (object-place association task). These tasks were performed in
a square plexiglas open field (52 cm × 52 cm) with black walls (40 cm
high) and a white floor divided into 25 equal squares by black lines. A
striped card was fixed against a wall. The device was illuminated by
an indirect halogen light (open field center, 40 lux), and a radio played
a background noise 2 m from the device (open field center, 45 ± 5 dB).
Nine different objects were used (two for the habituation phases, two
for the novel object recognition task, three for the spatial object location
task, and two for the object-place task), which differed in size (10 to
20 cm),material (metal, glass, or plastic), shape, and color. Each object
was available in duplicate or triplicate (one set for each trial). Between
each trial, the walls, floor, and objects were wiped with 70% ethanol.
Object exploration timewas recorded and defined as the nose pointing
toward the object within 1 cm. Before testing, all mice received a habit-
uation trial of 10 min with an object placed in the center of the open
field, returned to their home cage for 3 hours, and then received another
10-min habituation trial with a new object.
For the novel object recognition task, mice explored the config-
uration of two identical objects during a 10-min acquisition trial,
returned to their home cage for 3 hours, and then received a 10-min
retention trial, during which one of the familiar objects was replaced
by an unfamiliar new one. Amemory index was calculated and defined
as: (time spent exploring the new object − time spent exploring the
old object)/total exploration time for the two objects during the 10-min
retention trial.
For the spatial object location task, mice first explored the con-
figuration of three objects placed in three corners of the open field
(each approximately 10 cm from walls) during a 10-min acquisition
trial, returned to their home cage for 3 hours, and then received a 10-min
retention trial with a new spatial configuration resulting from the shift of
an object from one corner to the opposite free corner of the open
field. A memory index was calculated and defined as: (time spent
exploring the displaced object − average exploration time of nondis-
placed objects)/total exploration time for the three objects during the
10-min retention trial.
For the object-place association task, mice explored the config-
uration of two different objects during a 10-min acquisition trial,
returned to their home cage for 3 hours, and then received a 10-min
retention trial, during which the two initial objects were replaced by
two copies of one of these objects. Thus, apparently one known object
remained unchanged, while its copy took the place of the different
object. A memory index was calculated and defined as: (time spent8 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 on June 26, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
exploring the replacing object − time spent exploring the unchanged
object)/total exploration time for the two objects during the 10-min
retention trial.
Barnes maze.
The Barnes maze task (31) is particularly relevant for assessing spatial
navigation memory in mice because of their natural ability to find an
escape through small holes and their physiological adaptation to the
dry-land maze compared to their poor adaptation to tasks based on
water escape responses, such as in the Morris water maze (61). After
a 3-day habituation to the tube leading to the home cage of the mouse,
mice were trained for 5 days (three daily trials, 180-s cutoff, intertrial
interval of 15 min) to find the target hole among 12 identical holes
(diameter, 4 cm) equally distributed (space between holes, 15 cm) at
9 cm from the edge of a 1-cm-diameter circular board. During this
acquisition phase, the target hole was connected to the tube leading
to the home cage. The target hole was at a fixed location in the testing
room, which provided various extra-maze, auditory, olfactory, and
visual cues, such as the rack holding the cages of the other mice, a
background noise from a radio, which played 2m from the center of the
platform (maze center, 45 ± 5 dB), furniture, pictures, and an overhead
lighting (800 lux at the maze center). An opaque polyvinyl chloride
starting cylinder, placed in the center of the maze, was used to confine
the mice at the center of the platform before being lifted at the start of
each trial. Between trials, the maze and holes were wiped with 70%
ethanol and pseudorandomly rotated to minimize odor-based strat-
egies. For each trial, we evaluated the latency of the first visit to the
target hole (nose poke in the target hole). After the 5 days of acqui-
sition, mice were subjected to a probe test (120 s) with all the holes
closed. Preferential exploration of the target hole (calculated as the
ratio between the number of visits to the target hole and the total
number of hole visits) was considered to reflect good spatial naviga-
tion memory.
Pharmacology
To target APP metabolites and their behavioral impacts, mice were
treated by oral gavage with either the vehicle alone (hydroxypropyl
cellulose; Sigma-Aldrich), a b-secretase inhibitor (LY-2811376;MedChem
Express; 15 mg/kg every 2 days between 1 and 2 months of age), or a
g-secretase inhibitor (semagacestat; AbMole; 10mg/kgper day for 6 days).
The doses of the secretases were selected according to the studies of
May et al. (32) andMitani et al. (12), respectively. On the last 2 days of
treatment, animals were first tested in the spatial object location task
and then in the object-place association task. Three hours after the last
injection, a subset of treated mice were sacrificed with an overdose of
sodium pentobarbital (200mg/kg intraperitoneally) and decapitated.
Bilateral hippocampi were rapidly microdissected, frozen in liquid nitro-
gen, and stored at −80°C before ELISA andWestern blot quantifications.
Histological study
Perfusion and tissue preparation.
Mice were sacrificed with an overdose of sodium pentobarbital (200
mg/kg intraperitoneally) and transcardially perfused in 0.1% heparin
phosphate-buffered saline (PBS) and 4% paraformaldehyde [PFA; in
phosphate buffer (PB) pH7.4; 4°C]. Brainswere tidily removed, postfixed
in a 4% PFA solution for 24 hours, and cryoprotected in a saccharose
solution (20% in PB, 0.1M; pH 7.4; 4°C) for 48 hours before being frozen
with isopentane (−40°C) and subsequently stored at−80°C. Thin (20mm)
frontal brain sections from the dorsal hippocampus (bregma, −1.34 to
2.06 mm) were cut with a cryostat and mounted on gelatin slides.Hamm et al., Sci. Adv. 2017;3 : e1601068 24 February 2017Immunohistochemistry.
Sections were pretreated in 1% H2O2 (15 min) and in sodium citrate
(10 mM; pH 8; 30 min at 80°C). Sections were then rinsed in 0.1 M
PBS (3 × 10min) before being blocked in 5% donkey serum (1 hour),
followed by incubation with primary antibodies in 2% donkey serum
and 0.1%TritonX-100 (24 hours at 4°C).We usedmousemonoclonal
PV (Sigma; 1:4000), rabbit polyclonal SOM (Santa Cruz; 1:500), and
rabbit polyclonal c-Fos (Santa Cruz; 1:500) primary antibodies. The
next day, sections were rinsed three times in 0.1 M PBS (3 × 10 min)
before a 2-hour incubation in the dark with secondary antibodies
(anti-rabbit Alexa 488, 1:1000; antimouse Alexa 568, 1:1000; Invitrogen
Molecular Probes). Last, sections were rinsed three times in 0.1M PBS
(3× 10min) and rapidly in ultrapurewater before beingmountedwith
DAPI fluoromount (Southern Biotech). Cell quantification was done
as described in the study of Ducharme et al. (62). Briefly, one section
every 120 mmwas analyzed, whichmeans that four to six sections were
evaluated per animal. This set of sections encompassed the dorsal por-
tion of the hippocampus. Photomicrographs were captured using a
fluorescence microscope coupled to an ApoTome module (Zeiss),
and all labeled cells were counted bilaterally by an experimenter
blinded to the genotype. The cells were identified on the basis of shape
and size (roughly 10 to 20 mm in diameter), and cells with a large range
of staining intensity were included. The counts were performed for each
hippocampal subfield individually using the ImageJ software.
Statistical analyses
Analyses were done with GraphPad 6 (Prism). Data are expressed as
means ± SEM. Memory index was compared to the 0 chance level
(no detection of the new object or spatial change) with a one-sample
Student’s t test. Unpaired t tests were used to compare genotypes. All
the other analyses were done using a two-way ANOVA (with or with-
out repeated measures) except for the exploration time analysis with
pharmacological treatment, where three-way ANOVA was used
(Matlab). BecauseNTg- andTgCRND8-vehiclemice do not differ from
nontreated animals, they were sometimes pooled together to decrease
the number of animals used in the study. In case of significant ANOVA,
multiple comparisons among groups were performed using Bonferroni’s
multiple-comparisons test. The threshold for statistical significance was
set at P < 0.05. The experimenter was blinded to the treatment groups
until the end of behavioral testing.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/2/e1601068/DC1
fig. S1. Western blot using the 6E10 antibody and quantification of the levels of two forms of
the human APP: the full-length hAPP and the b-CTF.
fig. S2. Total exploration time during the spatial object location task.
fig. S3. Total exploration time during the object-place association task.
fig. S4. Relative visits to the target during the probe test of the Barnes maze task.
fig. S5. Total exploration time during the novel object recognition task.
fig. S6. Memory index in NTg animals following pharmacological treatment.
fig. S7. Total exploration time during the spatial object location task with pharmacological treatment.
fig. S8. Total exploration time during the object-place task with pharmacological treatment.REFERENCES AND NOTES
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